The impact of population based screening for carriers of cystic fibrosis
- PMID: 8064812
- PMCID: PMC1049866
- DOI: 10.1136/jmg.31.5.364
The impact of population based screening for carriers of cystic fibrosis
Abstract
The purpose of the study was to evaluate the short-term effects of population based screening for carriers of cystic fibrosis. The outcome measures included perceptions of health, anxiety, and understanding of test results. Those adults aged between 18 and 45, registered with a general practice in Inner London, who accepted the offer of carrier testing, completed questionnaires before testing, upon receipt of results, and three months later. Full data were obtained from 427 with negative test results and 14 carriers. Receipt of results had no effect upon perceptions of health or perceived risk of having an abnormal baby. Those receiving a positive test result were significantly more anxious upon receipt of this result. By three months, this anxiety had dissipated. While knowledge of the test improved from before to after testing, by three months there was some decay. Although the residual risk among those with a negative result of being a carrier was given as 1:135, at least 17% of those receiving a negative result incorrectly believed that they were at no risk of having a child with cystic fibrosis. Five of the 14 receiving a positive result erroneously believed that their results meant that they probably, but not definitely, carried the gene for cystic fibrosis. In the longer term the greatest problem of population screening would appear to be one of false reassurance rather than anxiety. Longer term studies are needed to determine how well carrier status information is retained, and how carriers and carrier couples plan and respond to pregnancy and how much understanding they retain of their test results.
Similar articles
-
Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.Lancet. 1996 May 25;347(9013):1443-6. doi: 10.1016/s0140-6736(96)91683-9. Lancet. 1996. PMID: 8676627
-
Uptake of cystic fibrosis testing in primary care: supply push or demand pull?BMJ. 1993 Jun 12;306(6892):1584-6. doi: 10.1136/bmj.306.6892.1584. BMJ. 1993. PMID: 8329922 Free PMC article. Clinical Trial.
-
Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.BMJ. 1995 Feb 11;310(6976):353-7. doi: 10.1136/bmj.310.6976.353. BMJ. 1995. PMID: 7866213 Free PMC article. Clinical Trial.
-
Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.Arch Intern Med. 1999 Jul 26;159(14):1529-39. Arch Intern Med. 1999. PMID: 10421275 Review.
-
Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research.Genet Med. 2014 Mar;16(3):207-16. doi: 10.1038/gim.2013.125. Epub 2013 Sep 12. Genet Med. 2014. PMID: 24030436
Cited by
-
Psychosocial Responses to being Identified as a Balanced Chromosomal Translocation Carrier: a Qualitative Investigation of Parents in Japan.J Genet Couns. 2015 Dec;24(6):922-30. doi: 10.1007/s10897-015-9828-6. Epub 2015 Mar 20. J Genet Couns. 2015. PMID: 25787091
-
Women's attitudes toward testing for fragile X carrier status: a qualitative analysis.J Genet Couns. 2005 Aug;14(4):295-306. doi: 10.1007/s10897-005-1159-6. J Genet Couns. 2005. PMID: 16047092
-
Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing?J Genet Couns. 2011 Feb;20(1):80-97. doi: 10.1007/s10897-010-9327-8. Epub 2010 Sep 29. J Genet Couns. 2011. PMID: 20878544 Review.
-
Social and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group.Genet Med. 2014 Oct;16(10):727-35. doi: 10.1038/gim.2014.26. Epub 2014 Mar 13. Genet Med. 2014. PMID: 24625446 Free PMC article. Review.
-
Implications of carrier identification in newborn screening for cystic fibrosis.Arch Dis Child Fetal Neonatal Ed. 2003 Nov;88(6):F467-71. doi: 10.1136/fn.88.6.f467. Arch Dis Child Fetal Neonatal Ed. 2003. PMID: 14602692 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical